A study of brenipatide to help former smokers stay smoke-free
Treatments studied
This trial tests an injectable drug called brenipatide to see if it helps people who have recently quit smoking stay quit for good. The study follows participants over time and requires them to come to clinic visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have stopped smoking very recently (within the last few days or weeks) and want to stay smoke-free.
- You are able to attend all study visits and follow instructions, including giving yourself injections of the study drug.
- You have not had a substance use problem (except for mild alcohol or cannabis use, or nicotine) in the last 6 months.
- You have not had suicidal thoughts or behaviors in the last 6 months.
- You do not have severe lung disease (like severe COPD) or other serious breathing problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an injectable medicine called brenipatide to help people with moderate-to-severe alcohol use disorder reduce or stop drinking. It is for adults who are motivated to change their drinking habits.
This trial tests a new medicine called Brenipatide to see if it can help people with moderate-to-severe COPD who still have symptoms despite using standard inhalers. The study will compare the effects of Brenipatide against a placebo to understand if it is safe and effective.
This trial tests an investigational drug called brenipatide for people with schizophrenia who are already on a stable medication regimen. The goal is to see if adding this drug helps reduce relapses.
This study tests an experimental medicine called brenipatide to help people reduce or stop drinking. It involves getting a daily injection and completing check-ins and questionnaires over several months.
This trial tests a new medicine called Brenipatide for people with opioid use disorder who are already taking buprenorphine but still occasionally use non-prescribed opioids. It aims to see if the study drug can help reduce opioid use.
This study tests whether tirzepatide, a medication that helps with weight and blood sugar, can also help people quit smoking. You'd receive the medication plus standard quitting support (nicotine patches or gum and a quit-smoking app) over several months.
Hear when a new Smoking trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.